Compare CNET & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNET | SCNI |
|---|---|---|
| Founded | 2003 | 2003 |
| Country | Hong Kong | Israel |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0M | 4.6M |
| IPO Year | N/A | N/A |
| Metric | CNET | SCNI |
|---|---|---|
| Price | $1.45 | $1.15 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.3K | ★ 36.2K |
| Earning Date | 11-14-2025 | 11-24-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $6,166,000.00 | $1,147,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.91 |
| Revenue Growth | N/A | ★ 303.87 |
| 52 Week Low | $0.96 | $0.86 |
| 52 Week High | $2.78 | $6.18 |
| Indicator | CNET | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 37.35 | 54.76 |
| Support Level | $1.23 | $0.99 |
| Resistance Level | $1.59 | $1.09 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | -0.01 | 0.03 |
| Stochastic Oscillator | 31.84 | 99.97 |
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as related data and technical services to small and medium enterprises in the PRC. It offers a variety channel of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of e-commerce O2O advertising and marketing services, and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.